Breaking News, World News and Taiwan News.

J&J Q3 profit drops 7% on higher research, production costs

By Linda A. Johnson--Johnson & Johnson's third-quarter profit fell 7 percent as increased research and production costs offset higher sales for its medicines and medical devices and new revenue from its biggest acquisition ever.

The maker of Tylenol, baby shampoo and prescription drugs said Tuesday that its net income was US$2.97 billion, or US$1.05 per share. That's down from US$3.2 billion, of US$1.15 per share, in 2011's third quarter.

Excluding one-time charges for research, the acquisition and litigation, earnings were US$3.5 billion, or US$1.25 per share.

Revenue rose 6.5 percent to US$17.05 billion, boosted nearly 6 percent by sales from Synthes Inc., a maker of surgical trauma equipment and orthopedic implants that J&J bought for US$19.7 billion in June.

The results beat Wall Street expectations for earnings of US$1.21 per share on revenue of US$17.01 billion.

Write a Comment
CAPTCHA Code Image
Type in image code
Change the code
 Receive China Post promos
 Respond to this email
WSJA
Subscribe  |   Advertise  |   RSS Feed  |   About Us  |   Career  |   Contact Us
Sitemap  |   Top Stories  |   Taiwan  |   China  |   Business  |   Asia  |   World  |   Sports  |   Life  |   Arts & Leisure  |   Health  |   Editorial  |   Commentary
Travel  |   Movies  |   TV Listings  |   Classifieds  |   Bookstore  |   Getting Around  |   Weather  |   Guide Post  |   Student Post  |   Terms of Use  |   Sitemap
  chinapost search